Assessment of Muscle Function and Physical Performance in Daily Clinical Practice

A position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

Charlotte Beaudart, Yves Rolland, Alfonso J. Cruz-Jentoft, Jürgen M. Bauer, Cornel Sieber, Cyrus Cooper, Nasser Al-Daghri, Islene Araujo de Carvalho, Ivan Bautmans, Roberto Bernabei, Olivier Bruyère, Matteo Cesari, Antonio Cherubini, Bess Dawson-Hughes, John A. Kanis, Jean Marc Kaufman, Francesco Landi, Stefania Maggi, Eugene McCloskey, Jean Petermans & 7 others Leocadio Rodriguez Mañas, Jean Yves Reginster, Regina Roller-Wirnsberger, Laura A. Schaap, Daniel Uebelhart, René Rizzoli, Roger A. Fielding

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

It is well recognized that poor muscle function and poor physical performance are strong predictors of clinically relevant adverse events in older people. Given the large number of approaches to measure muscle function and physical performance, clinicians often struggle to choose a tool that is appropriate and validated for the population of older people they deal with. In this paper, an overview of different methods available and applicable in clinical settings is proposed. This paper is based on literature reviews performed by members of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) working group on frailty and sarcopenia. Face-to-face meetings were organized afterwards where the whole group could amend and discuss the recommendations further. Several characteristics should be considered when choosing a tool: (1) purpose of the assessment (intervention, screening, diagnosis); (2) patient characteristics (population, settings, functional ability, etc.); (3) psychometric properties of the tool (test–retest reliability, inter-rater reliability, responsiveness, floor and ceiling effects, etc.); (4) applicability of the tool in clinical settings (overall cost, time required for the examination, level of training, equipment, patient acceptance, etc.); (5) prognostic reliability for relevant clinical outcomes. Based on these criteria and the available evidence, the expert group advises the use of grip strength to measure muscle strength and the use of 4-m gait speed or the Short Physical Performance Battery test to measure physical performance in daily practice. The tools proposed are relevant for the assessment of muscle weakness and physical performance. Subjects with low values should receive additional diagnostic workups to achieve a full diagnosis of the underlying condition responsible (sarcopenia, frailty or other).

Original languageEnglish
Pages (from-to)1-14
JournalCalcified Tissue International
Volume105
Issue number1
DOIs
Publication statusPublished - Jul 15 2019

Fingerprint

Musculoskeletal Diseases
Sarcopenia
Osteoarthritis
Osteoporosis
Economics
Muscles
Aptitude
Muscle Weakness
Muscle Strength
Hand Strength
Population Characteristics
Psychometrics
Costs and Cost Analysis
Equipment and Supplies
Population
Walking Speed

Keywords

  • Daily practice
  • Muscle function
  • Muscle strenght
  • Physical performance
  • Sarcopenia

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Orthopedics and Sports Medicine
  • Endocrinology

Cite this

Assessment of Muscle Function and Physical Performance in Daily Clinical Practice : A position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). / Beaudart, Charlotte; Rolland, Yves; Cruz-Jentoft, Alfonso J.; Bauer, Jürgen M.; Sieber, Cornel; Cooper, Cyrus; Al-Daghri, Nasser; Araujo de Carvalho, Islene; Bautmans, Ivan; Bernabei, Roberto; Bruyère, Olivier; Cesari, Matteo; Cherubini, Antonio; Dawson-Hughes, Bess; Kanis, John A.; Kaufman, Jean Marc; Landi, Francesco; Maggi, Stefania; McCloskey, Eugene; Petermans, Jean; Rodriguez Mañas, Leocadio; Reginster, Jean Yves; Roller-Wirnsberger, Regina; Schaap, Laura A.; Uebelhart, Daniel; Rizzoli, René; Fielding, Roger A.

In: Calcified Tissue International, Vol. 105, No. 1, 15.07.2019, p. 1-14.

Research output: Contribution to journalReview article

Beaudart, C, Rolland, Y, Cruz-Jentoft, AJ, Bauer, JM, Sieber, C, Cooper, C, Al-Daghri, N, Araujo de Carvalho, I, Bautmans, I, Bernabei, R, Bruyère, O, Cesari, M, Cherubini, A, Dawson-Hughes, B, Kanis, JA, Kaufman, JM, Landi, F, Maggi, S, McCloskey, E, Petermans, J, Rodriguez Mañas, L, Reginster, JY, Roller-Wirnsberger, R, Schaap, LA, Uebelhart, D, Rizzoli, R & Fielding, RA 2019, 'Assessment of Muscle Function and Physical Performance in Daily Clinical Practice: A position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)', Calcified Tissue International, vol. 105, no. 1, pp. 1-14. https://doi.org/10.1007/s00223-019-00545-w
Beaudart, Charlotte ; Rolland, Yves ; Cruz-Jentoft, Alfonso J. ; Bauer, Jürgen M. ; Sieber, Cornel ; Cooper, Cyrus ; Al-Daghri, Nasser ; Araujo de Carvalho, Islene ; Bautmans, Ivan ; Bernabei, Roberto ; Bruyère, Olivier ; Cesari, Matteo ; Cherubini, Antonio ; Dawson-Hughes, Bess ; Kanis, John A. ; Kaufman, Jean Marc ; Landi, Francesco ; Maggi, Stefania ; McCloskey, Eugene ; Petermans, Jean ; Rodriguez Mañas, Leocadio ; Reginster, Jean Yves ; Roller-Wirnsberger, Regina ; Schaap, Laura A. ; Uebelhart, Daniel ; Rizzoli, René ; Fielding, Roger A. / Assessment of Muscle Function and Physical Performance in Daily Clinical Practice : A position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). In: Calcified Tissue International. 2019 ; Vol. 105, No. 1. pp. 1-14.
@article{1eca89111dd14b1b8b8ca5613df9ee71,
title = "Assessment of Muscle Function and Physical Performance in Daily Clinical Practice: A position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)",
abstract = "It is well recognized that poor muscle function and poor physical performance are strong predictors of clinically relevant adverse events in older people. Given the large number of approaches to measure muscle function and physical performance, clinicians often struggle to choose a tool that is appropriate and validated for the population of older people they deal with. In this paper, an overview of different methods available and applicable in clinical settings is proposed. This paper is based on literature reviews performed by members of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) working group on frailty and sarcopenia. Face-to-face meetings were organized afterwards where the whole group could amend and discuss the recommendations further. Several characteristics should be considered when choosing a tool: (1) purpose of the assessment (intervention, screening, diagnosis); (2) patient characteristics (population, settings, functional ability, etc.); (3) psychometric properties of the tool (test–retest reliability, inter-rater reliability, responsiveness, floor and ceiling effects, etc.); (4) applicability of the tool in clinical settings (overall cost, time required for the examination, level of training, equipment, patient acceptance, etc.); (5) prognostic reliability for relevant clinical outcomes. Based on these criteria and the available evidence, the expert group advises the use of grip strength to measure muscle strength and the use of 4-m gait speed or the Short Physical Performance Battery test to measure physical performance in daily practice. The tools proposed are relevant for the assessment of muscle weakness and physical performance. Subjects with low values should receive additional diagnostic workups to achieve a full diagnosis of the underlying condition responsible (sarcopenia, frailty or other).",
keywords = "Daily practice, Muscle function, Muscle strenght, Physical performance, Sarcopenia",
author = "Charlotte Beaudart and Yves Rolland and Cruz-Jentoft, {Alfonso J.} and Bauer, {J{\"u}rgen M.} and Cornel Sieber and Cyrus Cooper and Nasser Al-Daghri and {Araujo de Carvalho}, Islene and Ivan Bautmans and Roberto Bernabei and Olivier Bruy{\`e}re and Matteo Cesari and Antonio Cherubini and Bess Dawson-Hughes and Kanis, {John A.} and Kaufman, {Jean Marc} and Francesco Landi and Stefania Maggi and Eugene McCloskey and Jean Petermans and {Rodriguez Ma{\~n}as}, Leocadio and Reginster, {Jean Yves} and Regina Roller-Wirnsberger and Schaap, {Laura A.} and Daniel Uebelhart and Ren{\'e} Rizzoli and Fielding, {Roger A.}",
year = "2019",
month = "7",
day = "15",
doi = "10.1007/s00223-019-00545-w",
language = "English",
volume = "105",
pages = "1--14",
journal = "Calcified Tissue International",
issn = "0171-967X",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Assessment of Muscle Function and Physical Performance in Daily Clinical Practice

T2 - A position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

AU - Beaudart, Charlotte

AU - Rolland, Yves

AU - Cruz-Jentoft, Alfonso J.

AU - Bauer, Jürgen M.

AU - Sieber, Cornel

AU - Cooper, Cyrus

AU - Al-Daghri, Nasser

AU - Araujo de Carvalho, Islene

AU - Bautmans, Ivan

AU - Bernabei, Roberto

AU - Bruyère, Olivier

AU - Cesari, Matteo

AU - Cherubini, Antonio

AU - Dawson-Hughes, Bess

AU - Kanis, John A.

AU - Kaufman, Jean Marc

AU - Landi, Francesco

AU - Maggi, Stefania

AU - McCloskey, Eugene

AU - Petermans, Jean

AU - Rodriguez Mañas, Leocadio

AU - Reginster, Jean Yves

AU - Roller-Wirnsberger, Regina

AU - Schaap, Laura A.

AU - Uebelhart, Daniel

AU - Rizzoli, René

AU - Fielding, Roger A.

PY - 2019/7/15

Y1 - 2019/7/15

N2 - It is well recognized that poor muscle function and poor physical performance are strong predictors of clinically relevant adverse events in older people. Given the large number of approaches to measure muscle function and physical performance, clinicians often struggle to choose a tool that is appropriate and validated for the population of older people they deal with. In this paper, an overview of different methods available and applicable in clinical settings is proposed. This paper is based on literature reviews performed by members of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) working group on frailty and sarcopenia. Face-to-face meetings were organized afterwards where the whole group could amend and discuss the recommendations further. Several characteristics should be considered when choosing a tool: (1) purpose of the assessment (intervention, screening, diagnosis); (2) patient characteristics (population, settings, functional ability, etc.); (3) psychometric properties of the tool (test–retest reliability, inter-rater reliability, responsiveness, floor and ceiling effects, etc.); (4) applicability of the tool in clinical settings (overall cost, time required for the examination, level of training, equipment, patient acceptance, etc.); (5) prognostic reliability for relevant clinical outcomes. Based on these criteria and the available evidence, the expert group advises the use of grip strength to measure muscle strength and the use of 4-m gait speed or the Short Physical Performance Battery test to measure physical performance in daily practice. The tools proposed are relevant for the assessment of muscle weakness and physical performance. Subjects with low values should receive additional diagnostic workups to achieve a full diagnosis of the underlying condition responsible (sarcopenia, frailty or other).

AB - It is well recognized that poor muscle function and poor physical performance are strong predictors of clinically relevant adverse events in older people. Given the large number of approaches to measure muscle function and physical performance, clinicians often struggle to choose a tool that is appropriate and validated for the population of older people they deal with. In this paper, an overview of different methods available and applicable in clinical settings is proposed. This paper is based on literature reviews performed by members of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) working group on frailty and sarcopenia. Face-to-face meetings were organized afterwards where the whole group could amend and discuss the recommendations further. Several characteristics should be considered when choosing a tool: (1) purpose of the assessment (intervention, screening, diagnosis); (2) patient characteristics (population, settings, functional ability, etc.); (3) psychometric properties of the tool (test–retest reliability, inter-rater reliability, responsiveness, floor and ceiling effects, etc.); (4) applicability of the tool in clinical settings (overall cost, time required for the examination, level of training, equipment, patient acceptance, etc.); (5) prognostic reliability for relevant clinical outcomes. Based on these criteria and the available evidence, the expert group advises the use of grip strength to measure muscle strength and the use of 4-m gait speed or the Short Physical Performance Battery test to measure physical performance in daily practice. The tools proposed are relevant for the assessment of muscle weakness and physical performance. Subjects with low values should receive additional diagnostic workups to achieve a full diagnosis of the underlying condition responsible (sarcopenia, frailty or other).

KW - Daily practice

KW - Muscle function

KW - Muscle strenght

KW - Physical performance

KW - Sarcopenia

UR - http://www.scopus.com/inward/record.url?scp=85066412818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066412818&partnerID=8YFLogxK

U2 - 10.1007/s00223-019-00545-w

DO - 10.1007/s00223-019-00545-w

M3 - Review article

VL - 105

SP - 1

EP - 14

JO - Calcified Tissue International

JF - Calcified Tissue International

SN - 0171-967X

IS - 1

ER -